Close Menu

Derek Lowe blogs at In the Pipeline about the potential future of drug discovery — once research moves beyond its limited, and limiting, work targeting drugs that only bind proteins. He reminds us of the universe of possibilities: proteins interacting with other proteins, DNA, RNA, carbohydrates, and lipids, which are some of the many targets that have yet to be fully explored for therapeutic value.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.